BDBM481127 US10906896, Cpd 806::US11725005, Compound 806

SMILES Cc1cc(on1)-c1cncc(c1)-c1ccnc(Nc2cc(NC(=O)c3ccc(CN4CCNCC4)cc3)ccc2C)n1

InChI Key InChIKey=OGFUMLMDBRBYKQ-UHFFFAOYSA-N

Data  1 KI  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 481127   

TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Inhibikase Therapeutics

US Patent
LigandPNGBDBM481127(US10906896, Cpd 806 | US11725005, Compound 806)
Affinity DataKi:  13nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Inhibikase Therapeutics

US Patent
LigandPNGBDBM481127(US10906896, Cpd 806 | US11725005, Compound 806)
Affinity DataIC50:  152nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Inhibikase Therapeutics

US Patent
LigandPNGBDBM481127(US10906896, Cpd 806 | US11725005, Compound 806)
Affinity DataIC50:  13nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Inhibikase Therapeutics

US Patent
LigandPNGBDBM481127(US10906896, Cpd 806 | US11725005, Compound 806)
Affinity DataIC50:  84nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Inhibikase Therapeutics

US Patent
LigandPNGBDBM481127(US10906896, Cpd 806 | US11725005, Compound 806)
Affinity DataIC50:  152nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Inhibikase Therapeutics

US Patent
LigandPNGBDBM481127(US10906896, Cpd 806 | US11725005, Compound 806)
Affinity DataIC50:  84nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent